Prime News, International/National, Bengaluru, July 25:- United States food and Drug Administration (USFDA) has given its approval to Bengaluru based Pharma Company Strides Shasun Ltd to market anti-allergic drug in the US.
The pharma company said that they had obtained approval from the USFDA for manufacturing their Cetirizine Softgel liquid-filled capsules of 10 mg in Bengaluru and marketing them in the US.
Cetirizine is an anti-histamine used to relieve allergy symptoms such as watery eyes, runny nose, itching in eyes, nose, sneezing, and hives.
The drug company in a statement released said that “We are the first Indian generic firm to receive the US regulatory approval for manufacturing and marketing the anti-allergy drug,” said the company.
The company said that the approval came after the recent regulatory inspection of the company’s Bengaluru production facility.”The product is ready for launch. As in the case of over the counter products (OTC), the market formation takes time, we expect to have a significant market share in six months,” it added.
According to the American market research firm IRI data, the United States market for the Cetirizine capsules is about USD60 million.
-(NAV, Inputs: Agencies)